Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.51 - $7.56 $1,545 - $22,906
3,030 Added 0.48%
630,369 $294,000
Q2 2022

Aug 12, 2022

SELL
$0.43 - $1.24 $180,910 - $521,696
-420,723 Reduced 40.14%
627,339 $386,000
Q1 2022

May 13, 2022

BUY
$0.74 - $1.79 $19,230 - $46,516
25,987 Added 2.54%
1,048,062 $1.26 Million
Q4 2021

Feb 11, 2022

BUY
$1.69 - $2.46 $16,078 - $23,404
9,514 Added 0.94%
1,022,075 $1.79 Million
Q3 2021

Nov 12, 2021

SELL
$2.38 - $3.77 $217,681 - $344,815
-91,463 Reduced 8.28%
1,012,561 $2.42 Million
Q2 2021

Aug 13, 2021

BUY
$3.49 - $5.51 $1.96 Million - $3.09 Million
560,876 Added 103.26%
1,104,024 $4.04 Million
Q1 2021

May 12, 2021

BUY
$5.37 - $10.72 $405,290 - $809,070
75,473 Added 16.14%
543,148 $3 Million
Q4 2020

Feb 12, 2021

BUY
$3.08 - $7.79 $360,141 - $910,876
116,929 Added 33.34%
467,675 $3.54 Million
Q3 2020

Nov 13, 2020

BUY
$2.02 - $3.08 $22,577 - $34,425
11,177 Added 3.29%
350,746 $712,000
Q2 2020

Aug 13, 2020

BUY
$2.1 - $3.42 $92,139 - $150,055
43,876 Added 14.84%
339,569 $994,000
Q1 2020

May 14, 2020

BUY
$2.31 - $4.43 $47,306 - $90,721
20,479 Added 7.44%
295,693 $706,000
Q4 2019

Feb 13, 2020

BUY
$2.82 - $12.9 $128,211 - $586,498
45,465 Added 19.79%
275,214 $1.22 Million
Q3 2019

Nov 12, 2019

BUY
$4.33 - $11.64 $134,178 - $360,700
30,988 Added 15.59%
229,749 $2.38 Million
Q2 2019

Aug 14, 2019

BUY
$4.6 - $10.13 $73,784 - $162,485
16,040 Added 8.78%
198,761 $1.14 Million
Q1 2019

May 14, 2019

BUY
$7.19 - $32.37 $105,196 - $473,605
14,631 Added 8.7%
182,721 $1.68 Million
Q4 2018

Feb 13, 2019

BUY
$21.32 - $46.34 $726,159 - $1.58 Million
34,060 Added 25.41%
168,090 $4.5 Million
Q3 2018

Nov 13, 2018

BUY
$36.35 - $51.7 $1.9 Million - $2.7 Million
52,214 Added 63.82%
134,030 $6.32 Million
Q2 2018

Aug 14, 2018

BUY
$7.33 - $43.15 $161,509 - $950,767
22,034 Added 36.86%
81,816 $2.92 Million
Q1 2018

May 15, 2018

BUY
$7.19 - $33.17 $429,832 - $1.98 Million
59,782 New
59,782 $448,000

Others Institutions Holding SLDB

About Solid Biosciences Inc.


  • Ticker SLDB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,533,080
  • Market Cap $36.5M
  • Description
  • Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...
More about SLDB
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.